CAR T Cell Therapy Market Size 2022 | Growing Opportunities, Challenges, Emerging-Demands, Trends, Explosive Factors of Revenue by Progression Status, Futuristic Growth, Share and Forecast

Kenneth Research, in its repository of market research reports, has recently added a report on CAR T Cell Therapy Marketthat emphasizes the latest trends, key opportunities, drivers, and challenges associated with the growth of the market during the forecast period, i.e., 2022 – 2031. The CAR T Cell Therapy Market  is anticipated to grow primarily on account of the growing trade of ICT goods and services worldwide. According to the statistics by the World Bank, the exports of ICT goods globally increased from 11.164% of total goods exports in 2017 to 11.53% of total goods exports in 2019.

Kenneth Research has recently added a report titled CAR T Cell Therapy Market  in its storehouse of market research reports. The report provides a detailed insight into the market scenario on the basis of the market size and volume for the forecast period, i.e., 2021 2030. Factors such as the growing advancements in the development of novel drugs, coupled with the growing health infrastructure in several nations worldwide are anticipated to drive the growth of the market in the coming years. Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth.

Request Free Sample Copy :- https://www.kennethresearch.com/sample-request-10159267

According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018. Moreover, growing concern for deaths caused due to various diseases and the need for treatment that can lower the crude death rate, which in the year 2019 recorded close to 7% (per 1000 people), are also anticipated to drive the market growth during the forecast period.

Global CAR T Cell Therapy Market: Information by Target Antigen (CD19, CD22 and others), Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma and others) and Region – Forecast till 2025
The Global CAR T Cell Therapy Market is anticipated to register a CAGR of 58.52% to attain USD 8716.06 Million by the year 2025.

In 2018, the worldwide GDP stood at USD 84,740.3 Billion as compared to the GDP of USD 80,144.5 Billion in 2017, marked a growth of 5.73% in 2018 over previous year according to the data quoted by International Monetary Fund. This is likely to impel the growth of CAR T Cell Therapy Market over the period 2019-2026.

The CAR T Cell Therapy Market report also focuses on the analysis on the basis of geography which includes North America (U.S. and Canada), Latin America (Mexico, Brazil, Argentina, Rest of Latin America), Europe (Germany, UK, France, Spain, Italy, NORDIC, BENELUX, Poland, Russia, Hungary, Rest of Europe), Asia Pacific (China, Japan, India, Australia, New Zealand, South Korea, Malaysia, Indonesia, Rest of Asia Pacific) and Middle East and Africa (GCC, North Africa, South Africa and Rest of Middle East and Africa).

In U.S., the GDP per capita was valued at USD 62,606 in 2018 as compared to USD 59,895 marked in 2017, observed a growth of 4.53% in 2018 over previous year. Rise in GDP per capita has intensified the growth of this market in the country.

Chimeric Antigen Receptor (CAR) T Cell Therapy is an immunotherapy that is used for cancer treatment. In this therapy, T cells from patient body are separated and introduced in the CAR gene so that the gene for the specific receptor binds to a certain protein on the patient’s cancer cells. The rising incidence of cancer across the world, technological advancement for advanced & reliable treatment for cancer, growing pharmaceutical industry, and growth in the number of cell therapy clinical studies are pushing the growth of the global CAR T cell therapy market.

However, side-effects of CAR T-cell therapy and high cost of treatment are likely to hinder the market growth. Growing frequency of cancer across the world, technological progress for advanced & reliable treatment for cancer, and increase in the number of cell therapy clinical studies are pushing the growth of the global CAR T cell therapy market. According to the National Cancer Institute, it is estimated that 1,735,350 new cases of cancer were diagnosed, and 609,640 deaths were reported in the US in 2018.

Download Sample of This Strategic Report- https://www.kennethresearch.com/sample-request-10159267

Moreover, the growing pharmaceutical industry is also expected to boost market growth. One of the main strategies followed by players operating in the global CAR T cell therapy market were innovation, product growth, and acquisitions & mergers. In April 2019, Autolus Therapeutics PLC was granted with an orphan drug designation, to autologous improved T-cells, inherently altered with a retroviral vector to express two chimeric antigen receptors targeting CD19 and CD22 (AUTO3) for the treatment of severe lymphoblastic leukemia (ALL), by the US FDA.

Market Segmentation

Global CAR T Cell Therapy Market has been segmented by Target Antigen, by application, and by region. Based on target antigen the market has been split into CD19, CD22, and Others. Based on application, the global CAR T Cell Therapy Market has been divided into Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma and Others. On the basis of region, the global CAR T Cell Therapy Market, by Region has been segmented US, Europe, China and Rest of the World

Regional Analysis

Geographically the global CAR T cell therapy market is split in regions like US, Europe, China, and the RoW. the major share of the global CAR T cell therapy market is expected to be held by US. This is owed to the growing cases of cancer in the country. Europe showed a significant amount of development in the market due to rise in the incidences of hematologic cancer such as leukemia, lymphoma, and multiple myeloma.

Europe held a market share of 9.15% in the global CAR T cell therapy market. China is projected to substantially increase in the global market due to the emerging healthcare infrastructure and rising disposable income. Also, the market in the Middle East & Africa is projected to show the least growth owing to limited healthcare access and affordability among the population.

Key Players

The proposed spectators in the global CAR T cell therapy market are Hospitals, Pharmaceutical companies, Biotechnology Companies, Research institutes, Contract Research Organizations, Academic institutes.

The major companies functioning in the global CAR T cell therapy market are concentrating on firming their global ways by entering into untouched markets. Pfizer, Inc. (US), Kite Pharma (US), Cellectis (France), Autolus Therapeutics PLC (UK), uno Therapeutics (US), Sorrento Therapeutics (US), (US), Mustang Bio (US), Novartis AG (Switzerland), CARsgen Therapeutics (China), Legend Biotech and others are some of the prominent players in the global CAR T cell therapy market.

Request For Full Report- https://www.kennethresearch.com/sample-request-10159267

About Us
Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defense, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research, are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.

Contact Us
Name: Kenneth research
Email: sales@kennethresearch.com
Phone: +1 313 462 0609

Metal Implants and Medical Alloys Market
Cough Syrup Market
Stroke Post Processing Software Market
Mortuary Equipment Market

Type-1 Diabetes Treatment Market

Related posts

Leave a Comment